Premium
Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
Author(s) -
Oechsner Matthias,
Korchounov Alexei
Publication year - 2005
Publication title -
human psychopharmacology: clinical and experimental
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.461
H-Index - 78
eISSN - 1099-1077
pISSN - 0885-6222
DOI - 10.1002/hup.682
Subject(s) - ziprasidone , psychosis , parkinson's disease , medicine , disease , psychiatry , anesthesia , pediatrics , quetiapine , schizophrenia (object oriented programming)
This is a report on a case series of five patiens with psychosis in Parkinson's disease who were treated successfully with an intramuscular injection of ziprasidone (10–20 mg) for acute agitation. No deterioration of motor function or other clinically relevant side effects were seen. Copyright © 2005 John Wiley & Sons, Ltd.